HLS Therapeutics Inc (DE:74D)

HLS Therapeutics Inc (74D) Financial Statements


HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 3.87%. HLS Therapeutics Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is €-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Jun 22
Income Statement-
Total Revenue$ 16.04M$ 16.42M$ 14.76M$ 15.68M$ 15.53M
Gross Profit$ 14.17M$ 14.64M$ 13.31M$ 14.16M$ 14.38M
EBIT$ -5.23M$ -7.39M$ -3.92M$ -4.60M$ -7.41M
EBITDA$ 2.98M$ 976.00K$ 4.40M-$ 1.08M
Net Income Common Stockholders$ -6.90M$ -9.44M$ -5.79M$ -6.43M$ -9.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.81M$ 20.93M$ 21.21M$ 20.72M$ 21.16M
Total Assets$ 215.23M$ 226.82M$ 234.16M$ 241.65M$ 266.63M
Total Debt$ 7.10M$ 13.01M$ 95.20M$ 100.05M$ 91.63M
Net Debt$ -14.71M$ -7.92M$ 73.98M$ 79.33M$ 70.47M
Total Liabilities$ 113.43M$ 115.38M$ 115.26M$ 116.33M$ 122.23M
Stockholders Equity$ 101.80M$ 111.44M$ 118.89M$ 125.32M$ 144.40M
Cash Flow-
Free Cash Flow$ 5.33M$ 2.53M$ 4.02M$ 3.50M$ 3.43M
Operating Cash Flow$ 5.37M$ 2.67M$ 4.02M$ 3.52M$ 3.51M
Investing Cash Flow$ -40.00K$ -135.00K-$ -20.00K$ -81.00K
Financing Cash Flow$ -4.29M$ -2.95M$ -3.51M$ -4.09M$ -4.80M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis